Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

HSV1 and 2 Detection in the CSF of Multiple Sclerosis Patients by Real-time PCR.
γδ T cells as early sensors of tissue damage and mediators of secondary neurodegeneration.
Role of a novel HLA-DQA1*01:02;DRB1*15:01 mixed-isotype heterodimer in the pathogenesis of 'humanized' multiple sclerosis-like disease.
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis.
Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis.
Duloxetine for the Treatment of Overactive Bladder Syndrome in Multiple Sclerosis: A Pilot Study.
Naturally Occurring Antibodies as Therapeutics for Neurologic Disease : Can Human Monoclonal IgMs Replace the Limited Resource IVIG?
Multiple sclerosis-like neurological manifestations in a coeliac patient: nothing is as it seems.
Cognitive functioning in pediatric transverse myelitis.
[Neurology at the border of centuries: achievements and prospects].
CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.
Neurobehavioral disorders.
Structural Analysis of Phenothiazine Derivatives as Allosteric Inhibitors of the MALT1 Paracaspase.
Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
Autoimmune disease: A role for new anti-viral therapies?
Depressive Symptoms in Multiple Sclerosis from an In Vivo Study with TBSS.
Identification of a unique TGF-β-dependent molecular and functional signature in microglia.
Cannabidiol: promise and pitfalls.
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.
The most fulminant course of the Marburg variant of multiple sclerosis-autopsy findings.
Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients.
Severe relapses under fingolimod treatment prescribed after natalizumab.
Early tolerability and safety of fingolimod in clinical practice.
Iron deposition in the precentral grey matter in patients with multiple sclerosis: A quantitative study using susceptibility-weighted imaging.
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.

Pages